Skip to Content

Adial Pharmaceuticals Inc

Rating as of

Company Profile

Business Description

Adial Pharmaceuticals Inc is a United States-based pharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is an approved drug for treating nausea and emesis.

1001 Research Park Boulevard, Suite 100
Charlottesville, VA, 22911
T +1 434 422-9800
Sector Healthcare
Industry Biotechnology
Most Recent Earnings Mar 31, 2020
Fiscal Year End Dec 31, 2020
Stock Type Distressed
Employees 4